Tarlatamb – 3rd line Small Cell

In this episode of the Medoncnow, Dr. Adrian Sacher joins us again and will help us understand how to incorporate Tarlatamab into our management strategy for Extensive Stage Small Cell Lung cancer. Key Opinion Leader:  Dr. Adrian Sacher Assistant Professor of Medicine and Immunology Staff Medical Oncologist and Affiliate Scientist Princess Margaret Cancer Centre University of Toronto Host: Shaqil Kassam MD. MSc. FRCPC skassam@southlake.ca Medical Oncologist Stronach Regional Cancer Centre, Newmarket, Ontario  X - @medoncnow

To be added to the distribution list, please email: DDeCastro@southlake.ca